Wall Street analysts will be watching closely when Colgate-Palmolive Company (NYSE:CL) reports its quarterly earnings next, which is scheduled for Fri 26 Apr (In 10 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $0.72 per share. In the preceding quarter, the company reportedly generated EPS of $0.74 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 23.70%, a profit margin of 15.40% and a gross margin of 59.60%.
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of Colgate-Palmolive Company (NYSE:CL). Most recently, on March 7th, 2019, Credit Suisse Initiated a Underperform rating. Before that, on February 11th, 2019, Exane BNP Paribas Upgrade to Neutral. Evercore ISI Initiated a Outperform rating on January 11th, 2019, Goldman Upgrade an Buy rating on January 9th, 2019, and JP Morgan Downgrade a Underweight rating on October 29th, 2018.
At its current price point, combined with the fact that this company has 866.70M shares outstanding, the current market capitalization sits at 59.84B. In the last trading day, 3,174,515 shares of Colgate-Palmolive Company were traded, which compares to its usual volume of about 3.76M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by $0.93 in the past five trading days, resulting in a percentage change of +1.37% and a moving average of 68.54. In the past 20 days, its price changed by $3.29 (which is +5.00%) and the stock’s moving average was 67.59. Looking back a full 50 days, shares of CL changed by $3.85 (which is +5.91%) and demonstrated a moving average of 66.63.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 92.55%, a 14-day Stochastic %K score of 93.95% and a 20-day Stochastic %K score of 96.75%. Using a similar metric, Colgate-Palmolive Company (CL) shares showed a Stochastic %D of 82.70% over the past 9 days, a Stochastic %D score of 90.74% over the last 14 days, and a 20-day Stochastic %D of 93.29%. Meanwhile, this stock’s MACD Oscillator was 0.58 over the past 9 days, 0.65 over the past two weeks, and 1.25 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $69.04 level. Over the past 12 months, this stock has experienced a high price of $72.61 and a low of $57.41. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
The Vanguard Group Inc purchased more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from Colgate-Palmolive Company (NYSE:CL) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 74,091,279 shares of the company’s stock following the addition of 1,861,968 to this investor’s holdings during the three-month period. This share count represents that The Vanguard Group Inc now held 8.62% stake in Colgate-Palmolive Company (CL)’s shares.
Just in the most recent trading day, Colgate-Palmolive Company (NYSE:CL) experienced a high price of $69.27 and low point of $68.72. At the end of the last trading session, this stock was at 69.04 per share, following a loss of -$68.71, or 0.48% during the full day.